Innovation Pharmaceuticals Inc. Contracts & Agreements
58 Contracts & Agreements
- Business Finance (39 contracts)
- Business Operations (2)
- Human Resources (9)
- Intellectual Property (1)
- Uncategorized (7)
- Series A Preferred Share Purchase Agreement, dated June 9, 2022, by and among Squalus Med Ltd. and Innovation Pharmaceuticals Inc (Filed With SEC on June 15, 2022)
- Amendments to the Innovation Pharmaceuticals Inc. 2016 Equity Incentive Plan, as amended (Filed With SEC on October 14, 2021)
- Form of Warrant (Filed With SEC on December 10, 2020)
- Securities Purchase Agreement, dated December 9, 2020, between the Company and the investor party thereto (Filed With SEC on December 10, 2020)
- Registration Rights Agreement, dated July 31, 2020, between Innovation Pharmaceuticals Inc. and Aspire Capital Fund, LLC (Filed With SEC on August 4, 2020)
- Common Stock Purchase Agreement, dated July 31, 2020, between Innovation Pharmaceuticals Inc. and Aspire Capital Fund, LLC (Filed With SEC on August 4, 2020)
- Form of Warrant Amendment Agreement, dated December 26, 2019, between the Company and each investor party thereto (Filed With SEC on December 26, 2019)
- Description of Class A common stock (Filed With SEC on September 30, 2019)
- Exclusive License Agreement, dated July 18, 2019, between Innovation Pharmaceuticals Inc. and Alfasigma S.p.A (Filed With SEC on July 22, 2019)
- Form of Series 4 Warrant (Filed With SEC on May 10, 2019)
- Form of Warrant Restructuring and Additional Issuance Agreement, dated May 9, 2019, between the Company and the investors party thereto (Filed With SEC on May 10, 2019)
- Form of Warrant (Filed With SEC on October 9, 2018)
- Securities Purchase Agreement, dated October 5, 2018, between the Company and the investors party thereto (Filed With SEC on October 9, 2018)
- Form of Warrant (Filed With SEC on June 29, 2018)
- Securities Purchase Agreement, dated June 28, 2018, between the Company and Aspire Capital Fund, LLC (Filed With SEC on June 29, 2018)
- Common Stock Purchase Agreement, dated as of September 6, 2017 by and between the Company and Aspire Capital Fund, LLC (Filed With SEC on September 11, 2017)
- Registration Rights Agreement, dated as of September 6, 2017 by and between the Company and Aspire Capital Fund, LLC (Filed With SEC on September 11, 2017)
- Form of Non-qualified Stock Option Agreement for the Innovation Pharmaceuticals Inc. 2010 Equity Incentive Plan (Filed With SEC on September 11, 2017)
- Form of Stock Purchase Agreement (Filed With SEC on March 31, 2017)
- FORM OF EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 1, 2016)
- CELLCEUTIX CORPORATION 2016 EQUITY INCENTIVE PLAN (Filed With SEC on July 1, 2016)
- Form of Incentive Stock Option Agreement (Filed With SEC on July 1, 2016)
- Form of Non-qualified Stock Option Agreement for Employees (Filed With SEC on July 1, 2016)
- Form of Non-qualified Stock Option Agreement for Non-employee Directors (Filed With SEC on July 1, 2016)
- Form of Restricted Stock Award Agreement for Employees (Filed With SEC on July 1, 2016)
- Form of Restricted Stock Award Agreement for Non-employee Directors (Filed With SEC on July 1, 2016)
- EXHIBIT 10.1 INDEPENDENT DIRECTOR AGREEMENT (Filed With SEC on April 27, 2015)
- EXHIBIT 10.1 COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on March 31, 2015)
- EXHIBIT 10.2 REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 31, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 24, 2014)
- AGREEMENT (Filed With SEC on September 2, 2014)
- AMENDMENT TO MENON- CELLCEUTIX AGREEMENT WITHOUT CHANGING THE TOTAL AMOUNT OF ROYALTIES PAYABLE UNDER THE TERMS OF THE PRIOR AGREEMENT (Filed With SEC on September 2, 2014)
- ASSIGNMENT (Filed With SEC on September 2, 2014)
- ASSET PURCHASE AGREEMENT dated as of July 29, 2013 by and among JEOFFREY L. BURTCH, THE CHAPTER 7 TRUSTEE FOR THE ESTATES OF POLYMEDIX, INC. AND POLYMEDIX PHARMACEUTICALS, INC. as... (Filed With SEC on September 9, 2013)
- FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (Filed With SEC on September 9, 2013)
- IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE (Filed With SEC on September 9, 2013)
- Mutual Termination Agreement (Filed With SEC on January 8, 2013)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 10, 2012)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 10, 2012)
- CELLCEUTIX CORPORATION SUBSCRIPTION AGREEMENT Series A Convertible Shares REGULATION D Dated: May 8, 2012 SECTION 1 (Filed With SEC on May 10, 2012)
- CELLCEUTIX CORPORATION SUBSCRIPTION AGREEMENT REGULATION D Dated:October 11,2011 SECTION 1 (Filed With SEC on October 13, 2011)
- ADDENDUM TO EHRLICH DEMAND UNSECURED NOTE KNOWN AS EHRLICH PROMISSORY NOTE C IN THE AMOUNT OF $1,750,000.00 DATED AUGUST 25, 2010 (Filed With SEC on May 23, 2011)
- SETTLEMENT AGREEMENT AND RELEASE (Filed With SEC on February 22, 2011)
- AMENDED AND RESTATED SECURITY AGREEMENT (Filed With SEC on February 22, 2011)
- AMENDED AND RESTATED GUARANTY (Filed With SEC on February 22, 2011)
- AMENDED AND RESTATED GUARANTY (Filed With SEC on February 22, 2011)
- CellceutixCorporation -and- Girindus America,Inc. ("Contractor") (Filed With SEC on October 8, 2009)
- SECURITYAGREEMENT (Filed With SEC on May 15, 2008)
- CONVERTIBLEPROMISSORYNOTE (Filed With SEC on May 15, 2008)
- GUARANTY (Filed With SEC on May 15, 2008)
- EMPLOYMENT AGREEMENT (Filed With SEC on December 12, 2007)
- EMPLOYMENT AGREEMENT (Filed With SEC on December 12, 2007)
- COMPOUND ASSIGNMENT AGREEMENT (Filed With SEC on December 12, 2007)
- COMPOUND ASSIGNMENT AGREEMENT (Filed With SEC on December 12, 2007)
- COMPOUND ASSIGNMENT AGREEMENT (Filed With SEC on December 12, 2007)
- COMPOUND ASSIGNMENT AGREEMENT (Filed With SEC on December 12, 2007)
- COMPOUND ASSIGNMENT AGREEMENT (Filed With SEC on December 12, 2007)